AI assistant
Sending…
GENTEX CORP — Director's Dealing 2019
Feb 1, 2019
30893_dirs_2019-02-01_cd763919-6bbd-496e-8dcc-1d10b55b8b0e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2019-01-31
Reporting Person: Wallace James H (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-31 | Common Stock | M | 12000.00 | $11.195 | Acquired | 29400.00 | Direct |
| 2019-01-31 | Common Stock | M | 12000.00 | $15.855 | Acquired | 41400.00 | Direct |
| 2019-01-31 | Common Stock | S | 24000.00 | $21.3961 | Disposed | 17400.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-01-31 | Non-employee Director Stock Option (Right to buy) | $15.855 | M | 12000.00 | Disposed | 2021-05-12 | Common Stock (12000.00) | Direct |
| 2019-01-31 | Non-employee Director Stock Option (Right to buy) | $11.195 | M | 12000.00 | Disposed | 2022-05-17 | Common Stock (12000.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $21.375 to $21.435. The price reported above reflects the weighted average price.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19